During the past decade, UNIFESP conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UNIFESP" #1 sponsor was "Federal University of São Paulo" with 3 trials, followed by "Ache Laboratorios Farmaceuticos S.A." with 1 trials sponsored, "Azidus Brasil" with 1 trials sponsored, "Biolab Sanus Farmaceutica" with 1 trials sponsored and "Danilo Forghieri Santaella" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNIFESP" #1 collaborator was "Cellavita Pesquisa Científica Ltda" with 1 trials as a collaborator, "Federal University of São Paulo" with 1 trials as a collaborator, "Hospital Vera Cruz" with 1 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator and "The International Society for Pediatric Neurosurgery" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "UNIFESP" are "Amyloidosis" (1 trials), "Arthritis, Rheumatoid" (1 trials), "CBCL" (1 trials), "COVID-19 Pneumonia" (1 trials) and "Chemotherapy-induced Diarrhea" (1 trials). Many other conditions were trialed in "UNIFESP" in a lesser frequency.

Most popular intervention types in "UNIFESP" are "Drug" (6 trials), "Other" (2 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Bronpheniramine and fenilefrine (Decongex Plus)" (1 trials), "Bronpheniramine isolated" (1 trials), "CSF Shunt Insertion" (1 trials) and "E2007 (perampanel)" (1 trials). Other intervention names were less common.

The vast majority of trials in "UNIFESP" are 12 trials for "All" genders.

Currently, there are NaN active trials in "UNIFESP". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in UNIFESP, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UNIFESP, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".